Originally broadcast: Tuesday 22nd September 2020
Duration: 90 minutes
Examine approaches to utilising Real World Evidence (RWE)
Guidance on collaborative working and horizon scanning
Discuss the NHS Long Term Plan and what this means for pharma companies
Harness digital systems and technology to find new levels of patient value
Understand the benefits of using research tools for market access
Who would benefit from registering to attend this webinar:
This webinar should be attended by representatives from UK, European and global pharmaceutical, biotech, life science and MedTech industries, as well as patient organisations and patient groups.
The job functions that will benefit most include:
• Heads of Market Access
• Managing Directors
• Country Managers
• Chief Executives
• Health Economists
• Medical Directors
• Commercial Directors
• Policy Officers/Executives
• Marketing Directors
• Policy Advisors
Andi is a health economist and the Director of the Health Economics Unit, an NHS organization that supports health & care, arm's-length bodies, charities industry & academia, locally, regionally and nationally, providing expertise in economics, population health, analytics & evaluations.
Andi is particularly interested in population health analytics especially how to best address health inequalities and the concept of impactibility modelling, finding people most amenable to intervention, and is researching this for his PhD at Imperial College London.
Andi is also a Senior Advisor for NHS England on Population Health Management in the Operations and Information Directorate. Andi works with STPs and ICSs across the country advising and working with them on population health management.
After completing a BSc in Sports Science, Darren went into applied human performance research before embarking in a career in healthcare / life science executive recruitment. Over the last 20 years, Darren has worked with most types of companies from pharma, biotech, CRO, medtech, health services, data and health tech. In 2016 he set up the EMIG Digital Health Special Interest Group where he brings digital companies and EMIG members together.
Copyright © 2020. MAP BioPharma Limited. All rights reserved.
MAP BioPharma Limited
Upper Pendrill Court, Ermine Street North
Papworth Everard, Cambridge
Cambridgeshire, CB23 3UY
+44 (0) 1480 832360
MAP BioPharma Limited is a registered company in England and Wales. Company Registration Number 08209281
VAT Group Registration Number GB 292 8576 52